Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTOC NASDAQ:III NASDAQ:MXCT NASDAQ:OPRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTOCArmlogi$1.56+2.6%$1.47$0.80▼$8.74$65.69M3.26183,369 shs2,556 shsIIIInformation Services Group$4.73-0.3%$4.78$2.95▼$5.28$227.75M1.21124,156 shs63,608 shsMXCTMaxCyte$2.16+1.7%$2.23$2.00▼$5.20$229.33M1.23612,249 shs147,370 shsOPRXOptimizeRx$14.47+2.1%$12.81$3.78▼$15.71$267.88M1.34303,207 shs147,423 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTOCArmlogi+1.33%+2.70%+0.66%+46.15%-68.66%IIIInformation Services Group-0.84%-5.95%-0.63%+27.42%+35.04%MXCTMaxCyte+0.47%-5.78%-5.36%-18.77%-58.10%OPRXOptimizeRx+9.25%+4.65%+2.90%+67.69%+34.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTOCArmlogi0.9238 of 5 stars0.04.00.00.02.71.70.0IIIInformation Services Group3.8187 of 5 stars2.55.01.70.03.02.51.9MXCTMaxCyte2.9253 of 5 stars3.54.00.00.02.21.70.6OPRXOptimizeRx1.7623 of 5 stars2.43.00.00.02.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTOCArmlogi 0.00N/AN/AN/AIIIInformation Services Group 3.00Buy$5.5016.40% UpsideMXCTMaxCyte 3.00Buy$7.50248.03% UpsideOPRXOptimizeRx 2.73Moderate Buy$10.81-25.25% DownsideCurrent Analyst Ratings BreakdownLatest BTOC, OPRX, III, and MXCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2025OPRXOptimizeRxStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$12.50 ➝ $16.005/13/2025OPRXOptimizeRxB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/13/2025OPRXOptimizeRxRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/13/2025OPRXOptimizeRxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/13/2025OPRXOptimizeRxStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.00 ➝ $12.505/13/2025OPRXOptimizeRxJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $14.005/12/2025IIIInformation Services GroupSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/12/2025IIIInformation Services GroupBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$3.75 ➝ $5.50(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTOCArmlogi$166.98M0.39$0.24 per share6.59$0.94 per share1.66IIIInformation Services Group$247.59M0.92$0.22 per share21.08$1.96 per share2.41MXCTMaxCyte$37.68M6.09N/AN/A$1.95 per share1.11OPRXOptimizeRx$92.13M2.90N/AN/A$6.35 per share2.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTOCArmlogi$7.44M-$0.23N/A∞N/A-5.31%-28.58%-5.89%9/24/2025 (Estimated)IIIInformation Services Group$2.84M$0.1531.5029.531.373.18%7.10%3.13%8/6/2025 (Confirmed)MXCTMaxCyte-$41.06M-$0.40N/AN/AN/A-110.92%-19.90%-17.24%8/5/2025 (Estimated)OPRXOptimizeRx-$18.66M-$0.84N/AN/A4.32-16.33%-0.29%-0.20%8/6/2025 (Estimated)Latest BTOC, OPRX, III, and MXCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025OPRXOptimizeRx$0.03N/AN/AN/A$22.27 millionN/A8/5/2025Q2 2025MXCTMaxCyte-$0.10N/AN/AN/A$9.57 millionN/A8/4/2025Q2 2025IIIInformation Services Group$0.07N/AN/AN/A$59.98 millionN/A5/14/2025Q3 2025BTOCArmlogiN/A-$0.09N/A-$0.09N/AN/A5/12/2025Q1 2025OPRXOptimizeRx-$0.11$0.08+$0.19-$0.12$18.69 million$21.93 million5/7/2025Q1 2025MXCTMaxCyte-$0.10-$0.10N/A-$0.10$9.05 million$10.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTOCArmlogiN/AN/AN/AN/AN/AIIIInformation Services Group$0.183.81%N/A120.00%1 YearsMXCTMaxCyteN/AN/AN/AN/AN/AOPRXOptimizeRxN/AN/AN/AN/AN/ALatest BTOC, OPRX, III, and MXCT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025IIIInformation Services Groupquarterly$0.04503.9%6/6/20256/6/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTOCArmlogiN/A0.930.93IIIInformation Services Group0.622.422.42MXCTMaxCyteN/A12.2311.58OPRXOptimizeRx0.252.822.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTOCArmlogiN/AIIIInformation Services Group73.10%MXCTMaxCyte68.81%OPRXOptimizeRx76.47%Insider OwnershipCompanyInsider OwnershipBTOCArmlogi72.92%IIIInformation Services Group15.90%MXCTMaxCyte3.30%OPRXOptimizeRx5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTOCArmlogiN/A42.11 million11.40 millionN/AIIIInformation Services Group1,32348.20 million40.54 millionNot OptionableMXCTMaxCyte80106.42 million102.90 millionOptionableOPRXOptimizeRx10018.50 million17.46 millionOptionableBTOC, OPRX, III, and MXCT HeadlinesRecent News About These CompaniesOptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ETJuly 17 at 7:30 AM | globenewswire.comOPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?July 16 at 10:31 AM | zacks.comOptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?July 11, 2025 | zacks.comBest Growth Stocks to Buy for July 9thJuly 9, 2025 | zacks.comCalamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX)July 8, 2025 | marketbeat.comInvestors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three yearsJuly 4, 2025 | finance.yahoo.comCan OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?July 4, 2025 | zacks.comOPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?July 3, 2025 | zacks.comOptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLCJune 30, 2025 | marketbeat.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 27, 2025 | marketbeat.comBest Growth Stocks to Buy for June 25thJune 25, 2025 | zacks.comOptimizeRx Corp. Appoints Steve Silvestro to Board of DirectorsJune 24, 2025 | quiverquant.comQOptimizeRx Corporation Appoints CEO Steve Silvestro to Board of DirectorsJune 24, 2025 | globenewswire.comCalculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)June 18, 2025 | finance.yahoo.comSimulmedia & OptimizeRx partner to bring Micro-Neighborhood® targeting to TV & streamingJune 18, 2025 | msn.comSimulmedia and OptimizeRx Announce Partnership from the Cannes LionsJune 18, 2025 | businesswire.comHere's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to BuyJune 6, 2025 | zacks.comNew Strong Buy Stocks for June 4thJune 4, 2025 | zacks.comEarnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?May 22, 2025 | zacks.comOptimizeRx to Participate in Upcoming Investor ConferencesMay 16, 2025 | globenewswire.comOptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBTOC, OPRX, III, and MXCT Company DescriptionsArmlogi NASDAQ:BTOC$1.56 +0.04 (+2.63%) As of 12:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Armlogi Holding Corp. is a warehousing and logistics service provider which offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment. Armlogi Holding Corp. is based in WALNUT, CA.Information Services Group NASDAQ:III$4.72 -0.02 (-0.32%) As of 12:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.MaxCyte NASDAQ:MXCT$2.15 +0.04 (+1.65%) As of 12:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.OptimizeRx NASDAQ:OPRX$14.46 +0.30 (+2.08%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
